Live feed
Filing
SC 13D
SC 13D0001306923-20-000003·Palo Alto Investors LP
Schedule 13D ownership disclosure
Aimmune Therapeutics, Inc.
Security class unavailable · CUSIP: 00900T107
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,380,441
- Percent of class
- 5.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001306923-20-000003
- Form type
- SC 13D
- Filer
- Palo Alto Investors LP
- CIK
- CIK 1306923
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13D beneficial ownership